Enasidenib Mesylate and Insulin aspart protamine and insulin aspart Subcutaneous
Determining the interaction of Enasidenib Mesylate and Insulin aspart protamine and insulin aspart Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: enasidenib
Brand name: Idhifa, Idhifa
Synonyms: Enasidenib
Generic Name: insulin aspart / insulin aspart protamine
Brand name: NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen, NovoLOG Mix 70/30 PenFill
Synonyms: Insulin aspart and insulin aspart protamine, Insulin Aspart Protamine and Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Enasidenib Mesylate-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Enasidenib Mesylate-Insulin Aspart Protamine and Insulin Aspart (Vials)
- Enasidenib Mesylate-Insulin Aspart Protamine Injection
- Enasidenib Mesylate-Insulin aspart, recombinant Subcutaneous
- Enasidenib Mesylate-Insulin degludec
- Enasidenib Mesylate-Insulin Degludec (U-100) Prefilled Pens
- Insulin aspart protamine and insulin aspart Subcutaneous-EnBrace HR
- Insulin aspart protamine and insulin aspart Subcutaneous-Enbrel
- Insulin aspart protamine and insulin aspart Subcutaneous-Enbrel (Etanercept Prefilled Syringes)
- Insulin aspart protamine and insulin aspart Subcutaneous-Enbrel (Etanercept Vials)
- Insulin aspart protamine and insulin aspart Subcutaneous-Enbrel SureClick
- Insulin aspart protamine and insulin aspart Subcutaneous-Encora